Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03379025

Effects of Electronic Cigarettes in Cigarette Smokers With Mild to Moderate COPD

Effects of Electronic Cigarettes on Smokers With Mild to Moderate Chronic Obstructive Pulmonary Disease

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of electronic cigarette use on cigarette smoking and markers of tobacco use, as well as respiratory symptoms and function in smokers with mild to moderate chronic obstructive pulmonary disease (COPD). All participants will receive a 12 week supply of electronic cigarettes to use instead of their regular conventional cigarettes.

Detailed description

Electronic cigarettes are devices that heat a solution containing nicotine to form an aerosol that is then inhaled by the user. Electronic cigarettes are used by many smokers, including smokers with chronic health conditions such as COPD. Given that e-cigarettes are still relatively new, their effects on health are not well defined. It is important to understand how electronic cigarettes affects symptoms and lung function in smokers with COPD to determine the short-term safety of these products. To do this, an initial step involves observing the extent to which smokers substitute their conventional cigarette use with electronic cigarette use and change their exposure to tobacco use biomarkers.

Conditions

Interventions

TypeNameDescription
OTHERElectronic cigaretteelectronic cigarette and cartridge refills (also known as pods)

Timeline

Start date
2019-10-01
Primary completion
2021-04-01
Completion
2021-08-01
First posted
2017-12-20
Last updated
2019-11-06

Source: ClinicalTrials.gov record NCT03379025. Inclusion in this directory is not an endorsement.